150 related articles for article (PubMed ID: 34599018)
1. Endogenous Plasma Kynurenic Acid in Human: A Newly Discovered Biomarker for Drug-Drug Interactions Involving Organic Anion Transporter 1 and 3 Inhibition.
Tang J; Shen H; Zhao X; Holenarsipur VK; Mariappan TT; Zhang Y; Panfen E; Zheng J; Humphreys WG; Lai Y
Drug Metab Dispos; 2021 Dec; 49(12):1063-1069. PubMed ID: 34599018
[TBL] [Abstract][Full Text] [Related]
2. Effect of probenecid on blood levels and renal elimination of furosemide and endogenous compounds in rats: Discovery of putative organic anion transporter biomarkers.
Thakur A; Saradhi Mettu V; Singh DK; Prasad B
Biochem Pharmacol; 2023 Dec; 218():115867. PubMed ID: 37866801
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Elimination Pathways and the Feasibility of Endogenous Metabolites as Biomarkers of Organic Anion Transporter 1/3 Inhibition in Cynomolgus Monkeys.
Liu R; Hao J; Zhao X; Lai Y
Drug Metab Dispos; 2023 Jul; 51(7):844-850. PubMed ID: 37059471
[TBL] [Abstract][Full Text] [Related]
4. Discovery and Validation of Pyridoxic Acid and Homovanillic Acid as Novel Endogenous Plasma Biomarkers of Organic Anion Transporter (OAT) 1 and OAT3 in Cynomolgus Monkeys.
Shen H; Nelson DM; Oliveira RV; Zhang Y; Mcnaney CA; Gu X; Chen W; Su C; Reily MD; Shipkova PA; Gan J; Lai Y; Marathe P; Humphreys WG
Drug Metab Dispos; 2018 Feb; 46(2):178-188. PubMed ID: 29162614
[TBL] [Abstract][Full Text] [Related]
5. Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions.
Britz H; Hanke N; Taub ME; Wang T; Prasad B; Fernandez É; Stopfer P; Nock V; Lehr T
Pharm Res; 2020 Nov; 37(12):250. PubMed ID: 33237382
[TBL] [Abstract][Full Text] [Related]
6. Investigation of Endogenous Compounds Applicable to Drug-Drug Interaction Studies Involving the Renal Organic Anion Transporters, OAT1 and OAT3, in Humans.
Tsuruya Y; Kato K; Sano Y; Imamura Y; Maeda K; Kumagai Y; Sugiyama Y; Kusuhara H
Drug Metab Dispos; 2016 Dec; 44(12):1925-1933. PubMed ID: 27638508
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the Validity of Pyridoxic Acid (PDA) as a Plasma-Based Endogenous Probe for OAT1 and OAT3 Function in Healthy Subjects.
Shen H; Holenarsipur VK; Mariappan TT; Drexler DM; Cantone JL; Rajanna P; Singh Gautam S; Zhang Y; Gan J; Shipkova PA; Marathe P; Humphreys WG
J Pharmacol Exp Ther; 2019 Jan; 368(1):136-145. PubMed ID: 30361237
[TBL] [Abstract][Full Text] [Related]
8. Detection of Weak Organic Anion-Transporting Polypeptide 1B Inhibition by Probenecid with Plasma-Based Coproporphyrin in Humans.
Zhang Y; Holenarsipur VK; Kandoussi H; Zeng J; Mariappan TT; Sinz M; Shen H
Drug Metab Dispos; 2020 Oct; 48(10):841-848. PubMed ID: 32723847
[TBL] [Abstract][Full Text] [Related]
9. Prediction of renal transporter-mediated drug-drug interactions for a drug which is an OAT substrate and inhibitor using PBPK modelling.
Ball K; Jamier T; Parmentier Y; Denizot C; Mallier A; Chenel M
Eur J Pharm Sci; 2017 Aug; 106():122-132. PubMed ID: 28552429
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans.
Maeda K; Tian Y; Fujita T; Ikeda Y; Kumagai Y; Kondo T; Tanabe K; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
Eur J Pharm Sci; 2014 Aug; 59():94-103. PubMed ID: 24747579
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetic modeling and simulation to support qualification of pyridoxic acid as endogenous biomarker of OAT1/3 renal transporters.
Ahmad A; Ogungbenro K; Kunze A; Jacobs F; Snoeys J; Rostami-Hodjegan A; Galetin A
CPT Pharmacometrics Syst Pharmacol; 2021 May; 10(5):467-477. PubMed ID: 33704919
[TBL] [Abstract][Full Text] [Related]
12. Blockade of Organic Anion Transport in Humans After Treatment With the Drug Probenecid Leads to Major Metabolic Alterations in Plasma and Urine.
Granados JC; Bhatnagar V; Nigam SK
Clin Pharmacol Ther; 2022 Sep; 112(3):653-664. PubMed ID: 35490380
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of
Parvez MM; Shin HJ; Jung JA; Shin JG
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223391
[No Abstract] [Full Text] [Related]
14. Investigation of Drug-Drug Interactions Between Ritobegron, a Selective β3 -Adrenoceptor Agonist, With Probenecid in Healthy Men.
Abe Y; Nakano Y; Kanazawa T; Furihata T; Endo T; Kobayashi M
Clin Pharmacol Drug Dev; 2016 May; 5(3):201-7. PubMed ID: 27163499
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic Evaluation of a Drug Transporter Cocktail Consisting of Digoxin, Furosemide, Metformin, and Rosuvastatin.
Stopfer P; Giessmann T; Hohl K; Sharma A; Ishiguro N; Taub ME; Zimdahl-Gelling H; Gansser D; Wein M; Ebner T; Müller F
Clin Pharmacol Ther; 2016 Sep; 100(3):259-67. PubMed ID: 27256812
[TBL] [Abstract][Full Text] [Related]
16. Interaction of five anthraquinones from rhubarb with human organic anion transporter 1 (SLC22A6) and 3 (SLC22A8) and drug-drug interaction in rats.
Ma L; Zhao L; Hu H; Qin Y; Bian Y; Jiang H; Zhou H; Yu L; Zeng S
J Ethnopharmacol; 2014 May; 153(3):864-71. PubMed ID: 24685584
[TBL] [Abstract][Full Text] [Related]
17. Aspirin and probenecid inhibit organic anion transporter 3-mediated renal uptake of cilostazol and probenecid induces metabolism of cilostazol in the rat.
Wang C; Wang C; Liu Q; Meng Q; Cang J; Sun H; Peng J; Ma X; Huo X; Liu K
Drug Metab Dispos; 2014 Jun; 42(6):996-1007. PubMed ID: 24692216
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor.
Taniguchi T; Ashizawa N; Matsumoto K; Saito R; Motoki K; Sakai M; Chikamatsu N; Hagihara C; Hashiba M; Iwanaga T
J Pharmacol Exp Ther; 2019 Oct; 371(1):162-170. PubMed ID: 31371478
[TBL] [Abstract][Full Text] [Related]
19. Interaction and transport of kynurenic acid via human organic anion transporters hOAT1 and hOAT3.
Uwai Y; Honjo H; Iwamoto K
Pharmacol Res; 2012 Feb; 65(2):254-60. PubMed ID: 22108572
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of an LC-MS/MS method to quantify kynurenic acid in human plasma.
Liu R; Zhao X; Geng G; Lai Y
Bioanalysis; 2022 Oct; 14(20):1327-1336. PubMed ID: 36473019
[No Abstract] [Full Text] [Related]
[Next] [New Search]
